Grant: Engage Grants Program
University of Calgary
$25,000.00
High-throughput microfluidic technology for developing small 3D tissues**
EF 2018-19
Résumé
Conventional cell-based assays offer the opportunity to investigate cell-cell, cell-tissue, and cell-drug interactions in two-dimensional (2D) culture systems. These assays are used extensively to perform screening a library of molecules that modulate a certain target among a broad range of biological events in tissues. However, the cost of phenotypic cell-based screening using conventional 2D models is prohibitive for many companies for large-scale screening of molecules. Also, the existing 3D tissue models do not still recapitulate basic requirements of a real 3D tissue such as the interaction of cells with the 3D matrix under controlled perfusion system. In this project, we will develop a new technology for generating realistic 3D tissues with much smaller size, useful to make effective biomolecules for engineering of cells or treatment of tissues. Such technology enables making more realistic tissues with mimetic cell-cell, cell-tissue, and cell-biomolecules interactions, and helps to make small tissues interacting with a very small volume of biomolecules in a high-throughput system. This 3D tissue model will drastically reduce the cost of testing biomolecules performance, making the large-scale screening of target molecules affordable. This work will also eliminate the challenge of cross-contamination among small tissues, something that is a critical challenge in all existing 3D tissue assays. These 3D tissue models will benefit SV ChemBiotech in developing cost-effective tissue models and drastically reducing the cost of testing biomolecules performance, providing the access to a new market for the company via making the large-scale screening of target molecules affordable.*
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
534035-2018
Name nom
SanatiNezhad, Amir
Department département
Mechanical and Manufacturing Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1206
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Engineering
Area of application fr
Génie
Research subject code
2100
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical engineering
Research subject fr
Génie mécanique
Partie
1
Nb partie
1
Application title
High-throughput microfluidic technology for developing small 3D tissues**
Keyword
NSERC
Application summary
Conventional cell-based assays offer the opportunity to investigate cell-cell, cell-tissue, and cell-drug interactions in two-dimensional (2D) culture systems. These assays are used extensively to perform screening a library of molecules that modulate a certain target among a broad range of biological events in tissues. However, the cost of phenotypic cell-based screening using conventional 2D models is prohibitive for many companies for large-scale screening of molecules. Also, the existing 3D tissue models do not still recapitulate basic requirements of a real 3D tissue such as the interaction of cells with the 3D matrix under controlled perfusion system. In this project, we will develop a new technology for generating realistic 3D tissues with much smaller size, useful to make effective biomolecules for engineering of cells or treatment of tissues. Such technology enables making more realistic tissues with mimetic cell-cell, cell-tissue, and cell-biomolecules interactions, and helps to make small tissues interacting with a very small volume of biomolecules in a high-throughput system. This 3D tissue model will drastically reduce the cost of testing biomolecules performance, making the large-scale screening of target molecules affordable. This work will also eliminate the challenge of cross-contamination among small tissues, something that is a critical challenge in all existing 3D tissue assays. These 3D tissue models will benefit SV ChemBiotech in developing cost-effective tissue models and drastically reducing the cost of testing biomolecules performance, providing the access to a new market for the company via making the large-scale screening of target molecules affordable.*